These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26017342)

  • 1. CTLA4 enhances the osteogenic differentiation of allogeneic human mesenchymal stem cells in a model of immune activation.
    Dai F; Zhang F; Sun D; Zhang ZH; Dong SW; Xu JZ
    Braz J Med Biol Res; 2015 Jul; 48(7):629-36. PubMed ID: 26017342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Osteogenesis by HVEM-Expressing Allogenic Bone Marrow-Derived Mesenchymal Stem Cells in an Immune Activation Condition and Mouse Femoral Defect Model.
    Rong Z; Zhang F; Wang Z; He W; Dong S; Xu J; Dai F
    Tissue Eng Part A; 2018 Aug; 24(15-16):1167-1178. PubMed ID: 29376477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses.
    de Mare-Bredemeijer EL; Mancham S; Verstegen MM; de Ruiter PE; van Gent R; O'Neill D; Tilanus HW; Metselaar HJ; de Jonge J; Kwekkeboom J; Hall SR; van der Laan LJ
    Stem Cells Dev; 2015 Jun; 24(12):1436-47. PubMed ID: 25744002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periostin promotes ectopic osteogenesis of CTLA4-modified bone marrow mesenchymal stem cells.
    Zhang F; Rong Z; Wang Z; Zhang Z; Sun D; Dong S; Xu J; Dai F
    Cell Tissue Res; 2017 Oct; 370(1):143-151. PubMed ID: 28687929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphB4 Promotes Osteogenesis of CTLA4-Modified Bone Marrow-Derived Mesenchymal Stem Cells Through Cross Talk with Wnt Pathway in Xenotransplantation.
    Zhang F; Zhang Z; Sun D; Dong S; Xu J; Dai F
    Tissue Eng Part A; 2015 Sep; 21(17-18):2404-16. PubMed ID: 26132739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.
    Inoue S; Popp FC; Koehl GE; Piso P; Schlitt HJ; Geissler EK; Dahlke MH
    Transplantation; 2006 Jun; 81(11):1589-95. PubMed ID: 16770249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?
    Griffin MD; Ryan AE; Alagesan S; Lohan P; Treacy O; Ritter T
    Immunol Cell Biol; 2013 Jan; 91(1):40-51. PubMed ID: 23207278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation.
    Nold P; Hackstein H; Riedlinger T; Kasper C; Neumann A; Mernberger M; Fölsch C; Schmitt J; Fuchs-Winkelmann S; Barckhausen C; Killer M; Neubauer A; Brendel C
    Cytotherapy; 2015 Feb; 17(2):152-62. PubMed ID: 25453724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
    Casiraghi F; Perico N; Cortinovis M; Remuzzi G
    Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro.
    Niemeyer P; Kornacker M; Mehlhorn A; Seckinger A; Vohrer J; Schmal H; Kasten P; Eckstein V; Südkamp NP; Krause U
    Tissue Eng; 2007 Jan; 13(1):111-21. PubMed ID: 17518585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
    Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
    Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mesenchymal stem cells and their immunological properties].
    Lisianyĭ MI
    Fiziol Zh (1994); 2013; 59(3):126-34. PubMed ID: 23957174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy.
    Naji A; Rouas-Freiss N; Durrbach A; Carosella ED; Sensébé L; Deschaseaux F
    Stem Cells; 2013 Nov; 31(11):2296-303. PubMed ID: 23922260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demineralized bone matrix combined with cytotoxic T-lymphocyte-associated protein 4 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells and suppresses the activation of T lymphocytes in vitro.
    Song L; Zhou R; Xiao J; He L; Zhu F; Li C; Dai F
    J Tissue Eng Regen Med; 2022 Mar; 16(3):290-296. PubMed ID: 34965018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts.
    Eggenhofer E; Steinmann JF; Renner P; Slowik P; Piso P; Geissler EK; Schlitt HJ; Dahlke MH; Popp FC
    Transpl Immunol; 2011 Apr; 24(3):157-63. PubMed ID: 21194567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
    Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
    Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation.
    Longoni B; Szilagyi E; Quaranta P; Paoli GT; Tripodi S; Urbani S; Mazzanti B; Rossi B; Fanci R; Demontis GC; Marzola P; Saccardi R; Cintorino M; Mosca F
    Diabetes Technol Ther; 2010 Jun; 12(6):435-46. PubMed ID: 20470228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth.
    Zheng H; Zou W; Shen J; Xu L; Wang S; Fu YX; Fan W
    Stem Cells Transl Med; 2016 Sep; 5(9):1216-28. PubMed ID: 27352928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immune Response to Allogeneic Differentiated Mesenchymal Stem Cells in the Context of Bone Tissue Engineering.
    Kiernan CH; Wolvius EB; Brama PAJ; Farrell E
    Tissue Eng Part B Rev; 2018 Feb; 24(1):75-83. PubMed ID: 28816104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
    Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.